The correct way to take Trametinib (Megenin) and the recommended dosage time and intervals

Trametinib (Trametinib, trade name: Mekinist) is an oral small molecule MEK inhibitor, mainly used to treat BRAF Patients with advanced melanoma and some non-small cell lung cancer with V600E or V600K mutations. It blocks the proliferation and growth of tumor cells by inhibiting the MEK protein downstream of the MAPK signaling pathway. Trametinib is often combined with a BRAF inhibitor (such as dabrafenib) to enhance efficacy and delay drug resistance.

The recommended dosage for adult patients is Trametinib once daily, 2 mg each time. The tablet should be swallowed whole and should not be crushed or chewed to ensure drug absorption and bioavailability. Take it at least 1 hours before meals or at least 2 hours after meals. However, it is recommended to keep the daily dosage time consistent to maintain stable blood concentration.

Trametinib is administered once daily, ideally at a fixed interval of 24 hours. If used in combination with a BRAF inhibitor, the medication should be coordinated according to the administration time of the combined drug. Generally, the BRAF inhibitor is administered twice daily, while trametinib remains once daily. Patients should try to take the medicine at the same time every day and avoid missing or repeated doses to ensure efficacy and safety.

If you miss a dose of trametinib, you should take it as soon as possible. However, if it is close to the next dose time, skip the missed dose and do not take double dose. Blood pressure, liver function, electrocardiogram, skin condition and other indicators should be monitored regularly during treatment to detect potential side effects. Patients should strictly follow the doctor's instructions and avoid stopping the medication at will or adjusting the dosage on their own to ensure the efficacy and reduce the risk of adverse reactions.

Reference materials:https://www.drugs.com/